Difference between revisions of "Special:Badtitle/NS100:Algorithms"

From NAMIC Wiki
Jump to: navigation, search
Line 14: Line 14:
 
#Applies to a broad range of diseases, in a broad range of organs.
 
#Applies to a broad range of diseases, in a broad range of organs.
  
 +
The groups that participate in this core are among the top medical image computing research groups in the world.
 +
 +
 +
To focus the technical development of these tools, as well as to address critical health care issues, the initial driving biological projects (DBPs) for the development and deployment of these computational methods came from the study of schizophrenia, and subsequently from lupus, autism, velocardiofacial syndrome (VCSF), and prostate cancer, as detailed in [[Projects/NAMICWeb:Driving Biological Projects|'''Core 3''']]. These tools are being designed to apply, with minimal amplification or modification, to other critical medical needs including multiple sclerosis, Alzheimer’s disease, epilepsy, prenatal alcohol syndrome. Moreover, we expect to continue to develop other potential collaborations in other diseases as our center evolves.
  
The groups that participate in this core are among the top medical image computing research groups in the world.
 
 
<gallery Caption="Algorithm Core Members" widths="100px" heights="75px" perrow="5">
 
<gallery Caption="Algorithm Core Members" widths="100px" heights="75px" perrow="5">
 
image:SCI logo.jpg|Ross Whitaker, Guido Gerig, [http://www.sci.utah.edu SCI Institute], U of Utah
 
image:SCI logo.jpg|Ross Whitaker, Guido Gerig, [http://www.sci.utah.edu SCI Institute], U of Utah
Line 23: Line 26:
 
image:Georgia-tech-logo.gif|Allen Tannenbaum, [http://www.bme.gatech.edu BME], Georgia Tech
 
image:Georgia-tech-logo.gif|Allen Tannenbaum, [http://www.bme.gatech.edu BME], Georgia Tech
 
</gallery>
 
</gallery>
 
 
To focus the technical development of these tools, as well as to address critical health care issues, the initial driving biological projects (DBPs) for the development and deployment of these computational methods came from the study of schizophrenia, and subsequently from lupus, autism, velocardiofacial syndrome (VCSF), and prostate cancer, as detailed in [[Projects/NAMICWeb:Driving Biological Projects|'''Core 3''']]. These tools are being designed to apply, with minimal amplification or modification, to other critical medical needs including multiple sclerosis, Alzheimer’s disease, epilepsy, prenatal alcohol syndrome. Moreover, we expect to continue to develop other potential collaborations in other diseases as our center evolves.
 

Revision as of 12:37, 8 September 2007


Algorithms

Big-Algorithm-Logo.png

The goal of this inter-disciplinary, multi-institutional center is to create, develop, integrate and deploy computation tools for the analysis and visualization of medical image data.

This analysis:

  1. Occurs at a range of scales, starting at the scale of organs, and ranging down to the scale of cells;
  2. Occurs across a range of modalities, starting with structural, functional and diffusion MRI, quantitative EEG, and metabolic and receptor PET, and extends to include microscopic, genomic and other image data;
  3. Applies to image data from individual patients, and to studies executed across large populations;
  4. Applies to image data of subjects taken across a wide range of time scales; and
  5. Applies to a broad range of diseases, in a broad range of organs.

The groups that participate in this core are among the top medical image computing research groups in the world.


To focus the technical development of these tools, as well as to address critical health care issues, the initial driving biological projects (DBPs) for the development and deployment of these computational methods came from the study of schizophrenia, and subsequently from lupus, autism, velocardiofacial syndrome (VCSF), and prostate cancer, as detailed in Core 3. These tools are being designed to apply, with minimal amplification or modification, to other critical medical needs including multiple sclerosis, Alzheimer’s disease, epilepsy, prenatal alcohol syndrome. Moreover, we expect to continue to develop other potential collaborations in other diseases as our center evolves.